… acquisition of the US biopharmaceutical firm Nuvalent. The firm is using generative AI to scan internal and external data to tailor treatments and …
Discover more from DrWeb's Domain
Subscribe to get the latest posts sent to your email.
GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares | FirstWord Pharma
